|
HU177578B
(en)
|
1976-08-27 |
1981-11-28 |
Chinoin Gyogyszer Es Vegyeszet |
Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives
|
|
DE2651083A1
(de)
|
1976-11-09 |
1978-05-18 |
Hoechst Ag |
Neue o-alkylierte hydroxylamine, verfahren zu ihrer herstellung und ihre verwendung
|
|
AU645243B2
(en)
|
1988-03-18 |
1994-01-13 |
General Hospital Corporation, The |
Human heat shock factor
|
|
HU207988B
(en)
|
1988-10-20 |
1993-07-28 |
Biorex Kutato Fejlesztoe Kft |
Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
|
|
HUT54347A
(en)
|
1989-01-10 |
1991-02-28 |
Chinoin Gyogyszer Es Vegyeszet |
Improved process for producing amidoximes
|
|
US5348945A
(en)
|
1990-04-06 |
1994-09-20 |
Wake Forest University |
Method of treatment with hsp70
|
|
US5334600A
(en)
|
1991-07-30 |
1994-08-02 |
Ciba-Geigy Corporation |
Isoquinolyl substituted hydroxylamine derivatives
|
|
ES2171454T3
(es)
|
1993-06-04 |
2002-09-16 |
Whitehead Biomedical Inst |
Proteinas de estres y sus usos.
|
|
WO1995025744A1
(en)
|
1994-03-21 |
1995-09-28 |
Rijksuniversiteit Utrecht |
Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases
|
|
US5919796A
(en)
|
1994-05-06 |
1999-07-06 |
Biorex Kutato Es Fejleszto Rt. |
Hydroximic acid derivatives, pharmaceutical compositions containing them, and processes for preparing the same
|
|
US5985270A
(en)
|
1995-09-13 |
1999-11-16 |
Fordham University |
Adoptive immunotherapy using macrophages sensitized with heat shock protein-epitope complexes
|
|
US5935576A
(en)
|
1995-09-13 |
1999-08-10 |
Fordham University |
Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
|
|
US5837251A
(en)
|
1995-09-13 |
1998-11-17 |
Fordham University |
Compositions and methods using complexes of heat shock proteins and antigenic molecules for the treatment and prevention of neoplastic diseases
|
|
HU9502843D0
(en)
|
1995-09-29 |
1995-11-28 |
Livigene Ltd |
Pharmaceutical composition
|
|
HU222994B1
(hu)
|
1995-11-02 |
2004-01-28 |
BIOREX Kutató és Fejlesztő Rt. |
Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
|
|
US5962313A
(en)
|
1996-01-18 |
1999-10-05 |
Avigen, Inc. |
Adeno-associated virus vectors comprising a gene encoding a lyosomal enzyme
|
|
UA64716C2
(en)
|
1996-08-09 |
2004-03-15 |
|
Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells
|
|
EP0950061A4
(en)
|
1996-09-20 |
2000-04-12 |
Univ New Mexico |
Heat shock protein complexes
|
|
US7157089B1
(en)
|
1996-11-26 |
2007-01-02 |
Stressgen Biotechnologies Corporation |
Immune responses using compositions containing stress proteins
|
|
US6017540A
(en)
|
1997-02-07 |
2000-01-25 |
Fordham University |
Prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress protein-peptide complexes
|
|
US5830464A
(en)
|
1997-02-07 |
1998-11-03 |
Fordham University |
Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
|
|
HU220971B1
(hu)
|
1997-04-03 |
2002-07-29 |
BIOREX Kutató és Fejlesztő Rt. |
Eljárás 0-(3-amino-2-hidroxi-propil)-hidroximsav-halogenidek előállítására
|
|
US6007821A
(en)
|
1997-10-16 |
1999-12-28 |
Fordham University |
Method and compositions for the treatment of autoimmune disease using heat shock proteins
|
|
US5948646A
(en)
|
1997-12-11 |
1999-09-07 |
Fordham University |
Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
|
|
BR9907228A
(pt)
|
1998-01-23 |
2000-10-24 |
Nat Jewish Med & Res Center |
Uso de uma proteìna de choque térmico, processo para proteger um mamìfero de uma doença, formulação para proteger um mamìfero de desenvolver uma doença, uso de uma molécula de ácido nucleico, e processo para prescrever um tratamento para hiper-sensibilidade das vias aéreas ou limitação do fluxo de ar associado com uma doença envolvendo resposta inflamatória
|
|
WO1999042121A1
(en)
|
1998-02-20 |
1999-08-26 |
University Of Miami |
Modified heat shock protein-antigenic peptide complex
|
|
WO1999049881A2
(de)
|
1998-03-27 |
1999-10-07 |
Gabriele Multhoff |
Verwendung von hsp70 protein
|
|
FR2777890B1
(fr)
|
1998-04-22 |
2000-12-29 |
Roussy Inst Gustave |
Composes peptidiques d'hsp70 utiles dans l'immunotherapie du cancer
|
|
US6274597B1
(en)
|
1998-06-01 |
2001-08-14 |
Mount Sinai School Of Medicine Of New York University |
Method of enhancing lysosomal α-Galactosidase A
|
|
UA65635C2
(uk)
|
1998-09-03 |
2004-04-15 |
Н-Гене Кутато Кфт. |
НЕНАСИЧЕНІ ПОХІДНІ ГІДРОКСИМОВОЇ КИСЛОТИ, ЩО МАЮТЬ ВЛАСТИВОСТІ ІНГІБІТОРІВ NAD<sup>+</sup>-ADP-РИБОЗИЛТРАНСФЕРАЗИ
|
|
US6475490B1
(en)
|
1998-10-19 |
2002-11-05 |
Fordham University |
Compositions and methods for promoting tissue repair using heat shock proteins
|
|
HU226617B1
(en)
|
1998-12-14 |
2009-04-28 |
Cytrx Corp |
Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, and pharmaceutical composition containing the compound as active ingredient
|
|
HUP9900475D0
(en)
*
|
1999-02-26 |
1999-04-28 |
Biorex Kutato Fejlesztoe Kft |
O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
|
|
CA2383213A1
(en)
|
1999-09-10 |
2001-03-15 |
Fordham University |
Methods and compositions for the treatment and prevention of graft rejection using heat shock proteins
|
|
US20020039583A1
(en)
|
1999-09-30 |
2002-04-04 |
Subjeck John R. |
Stress protein compositions and methods for prevention and treatment of cancer and infectious disease
|
|
US20030236300A1
(en)
|
1999-10-27 |
2003-12-25 |
Yale University |
Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease
|
|
WO2001034184A2
(en)
|
1999-11-05 |
2001-05-17 |
The Board Of Regents Of The University Of Nebraska |
Methods and compositions for protection against bovine herpesvirus 1
|
|
US6964851B2
(en)
|
1999-12-07 |
2005-11-15 |
Stressgen Biotechnologies Corp. |
Compositions and methods for detecting stress-inducible proteins
|
|
GB9930443D0
(en)
|
1999-12-22 |
2000-02-16 |
King S College London |
Novel use of heat shock proteins
|
|
US20020127219A1
(en)
|
1999-12-30 |
2002-09-12 |
Okkels Jens Sigurd |
Lysosomal enzymes and lysosomal enzyme activators
|
|
US20010034042A1
(en)
|
2000-01-20 |
2001-10-25 |
Srivastava Pramod K. |
Complexes of peptide-binding fragments of heat shock proteins and their use as immunotherapeutic agents
|
|
WO2001052877A1
(en)
|
2000-01-21 |
2001-07-26 |
University Of Connecticut Health Center |
Compositions and methods to treat neurodegenerative disorders
|
|
AU2001227960A1
(en)
|
2000-01-21 |
2001-07-31 |
University Of Connecticut Health Center |
Heat shock/stress protein complexes as vaccines against neurodegenerative disorders
|
|
HUP0001583A2
(hu)
*
|
2000-04-18 |
2002-11-28 |
BIOREX Kutató és Fejlesztő Rt. |
Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké
|
|
AU2001269923A1
(en)
|
2000-06-19 |
2002-01-02 |
Genzyme Corporation |
Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
|
|
AU2001277961A1
(en)
|
2000-08-07 |
2002-02-18 |
Antigenics, Llc |
Compositions comprising heat shock proteins or alpha(2)macroglobulin, antigenic molecules and saponins, and methods of use thereof
|
|
ES2326114T3
(es)
|
2000-09-13 |
2009-10-01 |
Multimmune Gmbh |
Un peptido de hsp70 estimulador de la actividad de las celulas asesinas naturales (nk) y los usos del mismo.
|
|
CA2422867A1
(en)
|
2000-09-15 |
2002-04-25 |
University Of Connecticut Health Center |
Improved formulations using heat shock/stress protein-peptide complexes
|
|
US20020172682A1
(en)
|
2000-10-20 |
2002-11-21 |
University Of Connecticut Health Center |
Using heat shock proteins to increase immune response
|
|
IT1319277B1
(it)
|
2000-10-24 |
2003-09-26 |
Chiesi Farma Spa |
Proteine di fusione utili per il trattamento di immunizzazione dellamalattia di alzheimer.
|
|
AU2002239462A1
(en)
|
2000-11-03 |
2002-06-03 |
The Board Of Regents Of The University Of Nebraska |
Compositions for protection against bovine viral diseases
|
|
EP1209226A3
(en)
|
2000-11-07 |
2002-06-05 |
GSF-Forschungszentrum für Umwelt und Gesundheit GmbH |
Maturation of dendritic cells by recombinant heat shock protein 70 (hsp70)
|
|
US20020142299A1
(en)
|
2001-01-09 |
2002-10-03 |
Davidson Beverly L. |
PTD-modified proteins
|
|
US7749971B2
(en)
|
2001-02-20 |
2010-07-06 |
Bedwell David M |
Aminoglycoside treatment for lysosomal storage diseases
|
|
CN1635896A
(zh)
|
2001-08-20 |
2005-07-06 |
康涅狄格大学健康中心 |
包含用于治疗癌症及感染性疾病的热休克蛋白或α2－巨球蛋白的组合物制备方法
|
|
JP2005512517A
(ja)
|
2001-09-27 |
2005-05-12 |
イ・デ・エム・イミュノ−デジネ・モレキュル |
誘導性Ｈｓｐ７０由来のポリペプチドとこのポリペプチドを含有する医薬組成物
|
|
HU0103939D0
(en)
|
2001-09-27 |
2001-11-28 |
Biorex Kutato Fejlesztoe Kft |
Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride
|
|
GB0123756D0
(en)
|
2001-10-03 |
2001-11-21 |
King S College London |
A novel chaperone-type of adjuvant for vaccination - Basic 1
|
|
US7125843B2
(en)
|
2001-10-19 |
2006-10-24 |
Neose Technologies, Inc. |
Glycoconjugates including more than one peptide
|
|
ITMI20012573A1
(it)
|
2001-12-06 |
2003-06-06 |
D B P Dev Biotechonologica L P |
Gli acilsalicilati:una nuova classe di induttori di risposta heat shock
|
|
JP2005514418A
(ja)
|
2002-01-11 |
2005-05-19 |
ビオレックス クタトー エス フェイレストェー アールテー． |
カルボキサミジン誘導体及び血管疾患の治療におけるそれらの使用
|
|
WO2003061684A2
(en)
|
2002-01-24 |
2003-07-31 |
Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw |
Tumour treatment compositions comprising hsp70 and tumour necrosis factor
|
|
US20030216315A1
(en)
|
2002-02-13 |
2003-11-20 |
Duke University |
Modulation of immune response by non-peptide binding stress response polypeptides
|
|
IL148401A0
(en)
|
2002-02-26 |
2002-09-12 |
Hadasit Med Res Service |
Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases
|
|
WO2003086452A2
(en)
|
2002-04-05 |
2003-10-23 |
Genzyme Corporation |
Methods of enhancing lysosomal storage disease therapy
|
|
WO2003090686A2
(en)
|
2002-04-25 |
2003-11-06 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
US6984389B2
(en)
|
2002-04-25 |
2006-01-10 |
University Of Connecticut Health Center |
Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
|
|
AU2003301296A1
(en)
|
2002-05-02 |
2004-05-04 |
University Of Connecticut Health Center |
Using heat shock proteins and alpha-2-macroglobulins to increase immune response to vaccines
|
|
JP2005533015A
(ja)
|
2002-05-02 |
2005-11-04 |
ユニバーシティー オブ コネティカット ヘルス センター |
抗体療法の有効性を増強するための熱ショックタンパク質の使用
|
|
GB0216414D0
(en)
|
2002-07-15 |
2002-08-21 |
Novartis Ag |
Organic compounds
|
|
US20070010434A1
(en)
|
2002-09-16 |
2007-01-11 |
Genetech, Inc. |
Novel compositions and methods for the treatment of immune related diseases
|
|
US8436136B2
(en)
|
2003-05-21 |
2013-05-07 |
Biotech Tools S.A. |
Peptide complex
|
|
US7244616B2
(en)
|
2003-06-27 |
2007-07-17 |
Bayer Pharmaceuticals Corporation |
Use of molecular chaperones for the enhanced production of secreted, recombinant proteins in mammalian cells
|
|
HUP0303584A3
(en)
|
2003-10-30 |
2009-12-28 |
Cytrx Corp |
Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
|
|
DE60335549D1
(de)
|
2003-11-12 |
2011-02-10 |
Alfa Biogene Internat B V |
Gewinnung von Hitzeschockproteinen
|
|
CN101214249A
(zh)
|
2003-11-25 |
2008-07-09 |
纽约大学西奈山医学院 |
尼曼-皮克病的基于陪伴分子的治疗
|
|
US7700737B2
(en)
|
2003-12-05 |
2010-04-20 |
Multimmune Gmbh |
Therapeutic and diagnostic anti-Hsp70 antibodies
|
|
US20060009520A1
(en)
|
2004-05-12 |
2006-01-12 |
Tall Alan R |
Retinoid-based methods for altering macrophage cholesterol
|
|
WO2005120558A2
(en)
|
2004-05-25 |
2005-12-22 |
University Of Connecticut Health Center |
Methods for making compositions comprising heat shock proteins or alpha-2-macroglobulin for the treatment of cancer and infectious disease
|
|
CA2590061A1
(en)
|
2004-12-10 |
2006-06-15 |
Zernike Business Support B.V. |
Hsp and supraventricular arrhythmia
|
|
AU2006254796B2
(en)
|
2005-06-08 |
2012-08-16 |
Amicus Therapeutics, Inc. |
Treatment of CNS disorders associated with mutations in genes encoding lysosomal enzymes
|
|
WO2007041285A2
(en)
|
2005-09-29 |
2007-04-12 |
Viral Genetics, Inc. |
Complexes of inactivated pepsin fraction and heat shock protein
|
|
EP1945632B1
(en)
|
2005-11-08 |
2013-09-18 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic modulators of atp-binding cassette transporters
|
|
US20080039400A1
(en)
|
2006-01-24 |
2008-02-14 |
Universiteit Utrecht Uu Holding B.V. |
Treatment and prevention of inflammatory bowel diseases
|
|
CA2640454A1
(en)
|
2006-01-26 |
2007-08-09 |
Foldrx Pharmaceuticals, Inc. |
Compounds and methods for modulating protein trafficking
|
|
KR20090019790A
(ko)
|
2006-05-19 |
2009-02-25 |
더 스크립스 리서치 인스티튜트 |
단백질 미스폴딩의 치료
|
|
WO2007150064A2
(en)
|
2006-06-23 |
2007-12-27 |
Amicus Therapeutics, Inc. |
METHOD FOR THE TREATMENT OF NEUROLOGICAL DISORDERS BY ENHANCING THE ACTIVITY OF β-GLUCOCEREBROSIDASE
|
|
WO2008005937A2
(en)
|
2006-06-30 |
2008-01-10 |
Sloan-Kettering Institute For Cancer Research |
Treatment of neurodegenerative diseases through inhibiton of hsp90
|
|
US20080044390A1
(en)
|
2006-08-11 |
2008-02-21 |
Xiaowei Jin |
Methods and compositions for the treatment of neurodegenerative disorders
|
|
CN101511872A
(zh)
|
2006-08-29 |
2009-08-19 |
为人技术株式会社 |
用于抑制凋亡的药物组合物及其递送方法
|
|
WO2008039514A1
(en)
|
2006-09-26 |
2008-04-03 |
Cytrx Corporation |
Pharmaceutical compositions and methods for treating diseases associated with neurodegeneration
|
|
MX2009005798A
(es)
|
2006-12-01 |
2009-08-12 |
Cytrx Corp |
Recuperacion de apoplejia.
|
|
EP2132309A4
(en)
|
2007-02-23 |
2011-01-05 |
Univ Florida |
COMPOSITIONS AND METHODS OF TREATING GLYCOLOGICAL MEMORY DISEASES
|
|
EP2155197A4
(en)
|
2007-03-09 |
2011-10-12 |
Link Medicine Corp |
TREATMENT OF LYSOSOMAL STORAGE DISEASES
|
|
GB0705626D0
(en)
|
2007-03-23 |
2007-05-02 |
Royal Veterinary College |
Method for enhancing sperm survival
|
|
WO2008127680A2
(en)
|
2007-04-11 |
2008-10-23 |
The Jackson Laboratory |
Diagnosis and treatment of diseases caused by misfolded proteins
|
|
JP5586453B2
(ja)
|
2007-04-13 |
2014-09-10 |
アミカス セラピューティックス インコーポレイテッド |
特異的薬理シャペロンによるゴーシェ病の治療および代理マーカーを用いた治療の監視
|
|
KR20190028822A
(ko)
|
2007-04-25 |
2019-03-19 |
사이토크로마 인코포레이티드 |
비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
|
|
MX2009011473A
(es)
|
2007-04-26 |
2010-01-18 |
Amicus Therapeutics Inc |
Regimenes de dosificacion para el tratamiento de enfermedades por almacenamiento lisosomal que utilizan chaperonas farmacologicas.
|
|
TW200901958A
(en)
|
2007-05-04 |
2009-01-16 |
Cytrx Corp |
Diabetic wound healing
|
|
GB0712494D0
(en)
|
2007-06-27 |
2007-08-08 |
Isis Innovation |
Substrate reduction therapy
|
|
US7678764B2
(en)
|
2007-06-29 |
2010-03-16 |
Johnson & Johnson Regenerative Therapeutics, Llc |
Protein formulations for use at elevated temperatures
|
|
US8742068B2
(en)
|
2007-07-06 |
2014-06-03 |
Universiteit Utrecht Holding B.V. |
Treatment and prevention of inflammatory diseases and autoimmune diseases
|
|
EP2195333A1
(en)
|
2007-09-12 |
2010-06-16 |
Anaphore, Inc. |
Hsp70-based treatment for autoimmune diseases
|
|
EP2252288A1
(en)
|
2007-11-21 |
2010-11-24 |
Summit Corporation Plc |
Treatment of protein folding disorders
|
|
CA2706727A1
(en)
|
2007-11-29 |
2009-06-11 |
Michael S. Mcgrath |
Compositions and methods for treating lysosomal disorders
|
|
US8354274B2
(en)
|
2008-01-30 |
2013-01-15 |
Geron Corporation |
Synthetic surfaces for culturing cells in chemically defined media
|
|
WO2009095452A1
(en)
|
2008-01-31 |
2009-08-06 |
Crystax Pharmaceuticals, S.L. |
Crystal structure of the atpase domain of proteins of the hsp70 family
|
|
EP2271213A4
(en)
|
2008-02-01 |
2011-06-29 |
Scripps Research Inst |
METHOD FOR THE TREATMENT OF A GRADE SUFFERED BY PROTEIN HOMEOSTASIS
|
|
JP5627571B2
(ja)
|
2008-05-07 |
2014-11-19 |
バイオマリン ファーマシューティカル インコーポレイテッド |
リソソーム標的化ペプチドおよびその使用
|
|
WO2009137796A2
(en)
|
2008-05-08 |
2009-11-12 |
Northwestern University |
Method of regulating the heat shock response
|
|
GB0809360D0
(en)
|
2008-05-22 |
2008-07-02 |
Isis Innovation |
Calcium modulation
|
|
US8540985B2
(en)
|
2008-06-26 |
2013-09-24 |
Orphazyme Aps |
Use of Hsp70 as a regulator of enzymatic activity
|
|
WO2010015816A2
(en)
|
2008-08-06 |
2010-02-11 |
Summit Corporation Plc |
Treatment of lysosomal storage disorders and other proteostatic diseases
|
|
WO2010022461A1
(en)
|
2008-08-29 |
2010-03-04 |
Children, Youth And Women's Health Service |
Sulphated sugars to increase activity of sulphatases en lysosomal storage disorders
|
|
JP2012504143A
(ja)
|
2008-09-29 |
2012-02-16 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
３−（６−（１−（２，２−ジフルオロベンゾ［ｄ］［１，３］ジオキソール−５−イル）シクロプロパンカルボキサミド）−３−メチルピリジン−２−イル）安息香酸の用量単位
|
|
WO2010053655A2
(en)
|
2008-11-07 |
2010-05-14 |
University Of Kansas |
Therapeutic methods with withaferin a and analogs
|
|
WO2010086418A1
(en)
|
2009-01-29 |
2010-08-05 |
Alfa Biogene International B.V. |
Functional food product comprising heat shock protein or a hydrolysate thereof
|
|
EP2218458A1
(en)
|
2009-02-13 |
2010-08-18 |
Fondazione Telethon |
Molecules able to modulate the expression of at least a gene involved in degradative pathways and uses thereof
|
|
US8932571B2
(en)
|
2009-03-10 |
2015-01-13 |
Alfa Biogene International B.V. |
Skin care product
|
|
GB0906159D0
(en)
|
2009-04-09 |
2009-05-20 |
Summit Corp Plc |
Drug combination for the treatment of proteostatic diseases
|
|
EP3679942A1
(en)
|
2009-06-17 |
2020-07-15 |
BioMarin Pharmaceutical Inc. |
Formulations for lysosomal enzymes
|
|
NZ713967A
(en)
|
2009-07-28 |
2017-01-27 |
Shire Human Genetic Therapies |
Compositions and methods for treating gaucher disease
|
|
US20120156180A1
(en)
|
2009-08-10 |
2012-06-21 |
The Board Of Trustees Of The University Of Illinois |
Compositions and methods for the treatment of krabbe and other neurodegenerative diseases
|
|
US20110081428A1
(en)
|
2009-09-16 |
2011-04-07 |
The Buck Institute For Age Research |
Use of thioflavin-like compounds to increase life span and/or health span
|
|
US8609416B2
(en)
|
2009-12-18 |
2013-12-17 |
Ventria Bioscience |
Methods and compositions comprising heat shock proteins
|
|
WO2012012656A2
(en)
|
2010-07-21 |
2012-01-26 |
University Of South Florida |
Materials and methods for treating neurodegenerative diseases
|
|
RU2013125923A
(ru)
|
2010-11-30 |
2015-01-10 |
Орфазиме Апс |
СПОСОБЫ УВЕЛИЧЕНИЯ ВНУТРИКЛЕТОЧНОЙ АКТИВНОСТИ Hsp70
|
|
CA2840224C
(en)
|
2011-06-22 |
2019-08-13 |
The General Hospital Corporation |
Treatment of proteinopathies
|
|
WO2013006076A1
(en)
|
2011-07-04 |
2013-01-10 |
New York University |
The use of intranasally administered hsp70 protein to treat neurodegenerative diseases
|
|
JP2015512913A
(ja)
|
2012-03-28 |
2015-04-30 |
ザ ユナイテッド ステイツ オブ アメリカ， アズ リプレゼンテッド バイ ザ セクレタリー， デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
グルコセレブロシダーゼ活性剤として有用なサリチル酸誘導体
|
|
AU2013337354A1
(en)
|
2012-11-05 |
2015-05-21 |
Genzyme Corporation |
Compositions and methods for treating proteinopathies
|
|
US9562110B2
(en)
|
2012-11-21 |
2017-02-07 |
Wuhan Yzy Biopharma Co., Ltd. |
Bispecific antibody
|
|
US10709700B2
(en)
*
|
2014-09-15 |
2020-07-14 |
Orphazyme A/S |
Arimoclomol formulation
|
|
KR20210059796A
(ko)
|
2016-04-29 |
2021-05-25 |
오르파짐 에이/에스 |
글루코세레브로시다제 연관 장애를 치료하기 위한 아리모클로몰
|
|
KR20230128462A
(ko)
*
|
2020-11-19 |
2023-09-05 |
제브라 덴마크 에이/에스 |
아리모클로몰 시트레이트 및 이의 중간체를 제조하기 위한 공정
|